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Ligand-induced type II interleukin-4 receptor
dimers are sustained by rapid re-association
within plasma membrane microcompartments
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The spatiotemporal organization of cytokine receptors in the plasma membrane is still
debated with models ranging from ligand-independent receptor pre-dimerization to
ligand-induced receptor dimerization occurring only after receptor uptake into endosomes.
Here, we explore the molecular and cellular determinants governing the assembly of the type
II interleukin-4 receptor, taking advantage of various agonists binding the receptor subunits
with different affinities and rate constants. Quantitative kinetic studies using artificial
membranes confirm that receptor dimerization is governed by the two-dimensional ligand–
receptor interactions and identify a critical role of the transmembrane domain in receptor
dimerization. Single molecule localization microscopy at physiological cell surface expression
levels, however, reveals efficient ligand-induced receptor dimerization by all ligands, largely
independent of receptor binding affinities, in line with the similar STAT6 activation potencies
observed for all IL-4 variants. Detailed spatiotemporal analyses suggest that kinetic trapping
of receptor dimers in actin-dependent microcompartments sustains robust receptor
dimerization and signalling.
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C
ytokines are first messenger proteins with key functions in
immunity and haematopoiesis. Cytokine signalling there-
fore has substantial potential for medical intervention and
several successful therapies have been approved1–3. Cytokines
engage their receptors by simultaneously interacting with two or
more receptor subunits, which in most cases activates
phosphorylation cascades via Janus family tyrosine kinases
associated with the cytoplasmic domain of the receptors. The
spatiotemporal organization of cytokine receptors in the plasma
membrane and in particular the role of receptor dimerization,
however, has remained controversially debated4–6. While
originally receptor dimerization by the ligand has been
proposed7, ligand-independent pre-dimerization of the receptor
subunits of homodimeric class I cytokine receptors was
observed8–11. A similar mechanism was reported to hold true
for several heterodimeric class I (refs 12–14) and class II cytokine
receptors15–17. Other reports suggest that ligand-independent
co-clustering of receptor subunits promoted by plasma
membrane microcompartmentation may support receptor
assembly18–21. Indeed, the relatively low, micromolar affinity of
many cytokines towards the accessory subunit implies that
recruitment of receptor subunits randomly distributed in the
plasma membrane could be rather inefficient, in particular
because many cytokine receptors are expressed at a level of
only a few 100 copies per cell22. To avoid artefacts caused by
receptor overexpression, we have developed single molecule
imaging techniques based on posttranslational labelling via
strictly monomeric tags to visualize and quantify receptor
dimerization in the plasma membrane of living cells at
physiological receptor expression levels23. Initial applications of
these techniques to class I and class II cytokine receptors were in
line with the original model of ligand-induced dimerization23–25.
Here, we focus on the assembly of the type II interleukin-4
(IL-4) receptor, which is structurally and functionally well
characterized26. This receptor, which is comprised of the two
subunits IL-4Ra and IL-13Ra1, can be activated by IL-4 and by
interleukin-13 (IL-13). IL-4 and IL-13 have been associated with
allergy, asthma and inhibition of autoimmunity2, but also seem to
be involved in cancer stem cell homeostasis27 and therefore the
receptor is a promising therapeutic target28,29. However, for
systematic drug development, a quantitative understanding of the
molecular and cellular determinants governing the receptor
activation at the cell surface is required, which so far remained
unresolved4: while a recent model proposed that dimerization of
IL-4Ra and IL-13Ra1 requires uptake into endosomes30,31, single
molecule studies suggested substantial receptor dimerization by
IL-13 at the plasma membrane25. IL-4 and IL-13 recognize the
receptor subunits IL-4Ra and IL-13Ra1 with differential affinity
and kinetics26: IL-4 binds to IL-4Ra with sub-nanomolar affinity
compared to the micromolar affinity interaction with IL-13Ra1
(B2.5 mM)32, which is B5-fold increased in presence of IL-4R-
EC (ref. 26). In contrast, IL-13 binds IL-13Ra1 with moderate
affinity (30 nM)26, while no interaction with IL-4Ra is
detectable32. The IL-13/IL-13Ra1-EC complex, however, binds
to IL-4Ra with a binding affinity of 10–20 nM (ref. 33). Recently,
IL-4 agonists with strongly altered affinities to IL-13Ra1 have
been generated34. Assuming a two-step dimerization model, a
complex assembly of IL-4Ra and IL-13Ra1 with substantially
different efficiency is expected for these different agonists,
depending on the affinity to the respective low-affinity subunit
(Fig. 1a).
Taking advantage of the versatile intrinsic and engineered
features of this system, here we aimed to identify the molecular
and cellular determinants governing the assembly and dynamics
of the type II IL-4 signalling complex in a quantitative manner.
For this purpose, we quantified receptor dimerization in artificial
membranes and in the plasma membrane of living cells. We
confirm that the two-dimensional equilibria and stabilities of
ternary ligand–receptor complexes reconstituted in artificial
membranes correlate with ligand binding affinities and kinetics.
Dual-colour single molecule imaging reveals random, uncorre-
lated distribution of individual IL-4Ra and IL-13Ra1 in the
plasma membrane, yet highly robust and efficient ligand-induced
dimerization. Interestingly, we find similar dimerization efficien-
cies for all ligands, despite their large differences in binding
affinity. More detailed analysis of the spatiotemporal receptor
dynamics suggests that plasma membrane microcompartmenta-
tion by the cortical actin cytoskeleton promotes efficient
re-association of dissociated receptor dimers, thus ensuring
robust maintenance of activated signalling complexes until
endocytosis.
Results
Dimerization critically depends on receptor densities. We
characterized the molecular features of the type II IL-4 receptor
assembly under well-defined conditions in vitro using a model
system based on solid-supported membranes (SSMs)35. For this
purpose, the ectodomains of IL-4Ra and IL-13Ra1 fused to a
C-terminal decahistidine tag (IL-4RaEC and IL-13Ra1-EC,
respectively) were tethered onto SSMs by means of a lipid
analogue functionalized with tris-NTA36. Thus, oriented
membrane anchoring and two-dimensional mobility of the
receptor subunits in the plane of the membrane was mimicked.
Receptor assembly was monitored by simultaneous total internal
reflection spectroscopy and reflectance interference (TIRFS-RIf)
detection35. For ligand binding assays, recombinant IL-4 variants
and IL-13 fused to an N-terminal ybbR-tag (11 amino acids) were
produced and site-specifically labelled by phosphopantetheinyl-
transfer using Coenzyme A conjugated with ATTO 488 or DY647
(ref. 37). All proteins were purified to monodispersity and
homogeneity as confirmed by size exclusion chromatography
(SEC) (Supplementary Fig. 1) and by SDS-PAGE (Supplementary
Fig. 2), respectively. In order to eliminate non-specific binding of
IL-4 to the complexed Ni(II) ions, the mutation H59Y outside the
receptor binding sites (Supplementary Fig. 3A) was introduced.
Neither the ybbR-tag nor the H59Y mutation affected receptor
binding properties or activity of IL-4 (Supplementary Fig. 4A,B)
and therefore these modifications will not be explicitly declared
in the following. Moreover, the mutation K84D (indicated by
the subscript D in the following) within the IL-4Ra binding
site (Supplementary Fig. 3B) was introduced in order to increase
the dissociation rate constant of the IL-4/IL-4Ra complex to a
similar level as of the IL-13/IL-13Ra1 complex. This mutation
also eliminated mass transport-limited association and
strong rebinding during dissociation observed for IL-4 as the
association rate constant of the IL-4/IL-4Ra interaction
was B10-fold reduced (from 1.3±0.3  107 M 1 s 1 to
1.7±0.4  106 M 1 s 1 (ref. 32)), thus ensuring unbiased
analyses of ligand dissociation curves. Importantly, the
interaction with IL-13Ra1 is not affected by this mutation
(Supplementary Fig. 4C). Therefore, the receptor assembly
mechanism depicted in Fig. 1a (left) can still be assumed valid
making this mutant suitable for probing the KTD of IL-13Ra1
recruitment into the ternary complex. Mutations and tagging as
well as labelling of all purified proteins used in this study are
summarized in Supplementary Tables 1 and 2.
After quantifying the rate constants of the fluorescently labelled
IL-4 variants and IL-13 interacting with the individual receptor
subunits by total internal reflection fluorescence spectroscopy
(TIRFS) detection (Supplementary Fig. 5 and Supplementary
Table 3), receptor dimerization was probed with both subunits
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tethered onto an SSM at surface concentrations of
B5 fmol mm 2 (B3,000 molecules per mm2) (Fig. 1b and
Supplementary Fig. 6). Dissociation of AT488IL-4D was substan-
tially slower compared to experiments with only IL-4Ra-EC
(Fig. 1c), which can be explained by recruitment of IL-13Ra1-EC
to form a ternary complex. The change in dissociation kinetics
was used for quantifying the equilibrium between binary and
ternary complexes by fitting a kinetic model schematically
depicted in the inset of Fig. 1b (ref. 35). Control experiments at
elevated IL-13Ra1-EC surface concentrations revealed
substantially further reduced dissociation kinetics (Fig. 1c) in
line with a shift of the two-dimensional equilibrium towards
ternary complex formation. Moreover, substantially enhanced
dissociation of AT488IL-4D was observed upon blocking free IL-
13Ra1-EC on the SSM by injection of IL-13 (Supplementary
Fig. 7). These results corroborate the formation of a dynamic
equilibrium between binary and ternary complexes as depicted in
Fig. 1a that can be quantified from the ligand dissociation
kinetics. From the fit of the ligand dissociation kinetics, a two-
dimensional (2D) equilibrium dissociation constant KTD of
(36±15) molecules per mm2 was obtained for the interaction of
IL-4Ra-EC/IL-4D with IL-13Ra1-EC.
Ligand binding affinities determine receptor dimerization. We
employed this assay to compare the dimerization by IL-4 mutants
with altered 3D binding affinities towards IL-13Ra1, namely RGA
(B5-fold increased KD) and KFR (B440-fold decreased KD)34 as
well as DN with no measurable affinity to IL-13Ra1 (ref. 38).
These mutants were combined with the H59Y and K84D
mutations for probing recruitment of IL-13Ra1-EC. The
expected shift in the equilibrium between binary and ternary
complexes compared to AT488IL-4D was clearly confirmed by
surface binding assays (Fig. 1d and Table 1): for AT488RGAD, a
IL-4Rα
IL-13Rα1IL-4 (wt, RGA, KFR)
+
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Figure 1 | Type II IL-4 receptor dynamics and dimerization quantified in vitro. (a) Two-step dimerization of the type II IL-4 receptor by different ligands.
Top: binding of IL-4 to IL-4Ra followed by recruitment of IL-13Ra1 at the membrane. For IL-4 mutants with altered affinities to IL-13Ra1, changes in the
equilibrium between binary and ternary complexes are expected. Bottom: binding of IL-13 to IL-13Ra1 followed by recruitment of IL-4Ra. (b) Typical binding
assay showing association (highlighted in grey) and dissociation of AT488IL-4D interaction with IL-4Ra-EC and IL-13Ra1-EC tethered on an SSM (TIRFS
signal only, full TIRFS-RIf experiment shown in Supplementary Fig. 6). The dissociation curve was fitted (black curve) by using a two-step disassembly
model (inset cartoon) to obtain the two-dimensional association rate constant kTa . (c) Comparison of the dissociation kinetics observed for
AT488IL-4D
interacting with IL-4Ra-EC (1.3 fmol mm 2) in absence of IL-13Ra1-EC and in presence of different IL-13Ra1-EC surface concentrations (ratios are indicated
at the curves). (d) Comparison of the dissociation kinetics obtained for AT488KFRD (green),
OG488IL-13 (light red), AT488IL-4D (violet),
AT488RGAD (orange)
and AT488DND (blue). Binary complex dissociation kinetics of
AT488IL-4D2IL-4Ra-EC (dark rose) and OG488IL-132IL-13Ra1-EC (red) are also depicted.
Table 1 | 2D kinetic and equilibrium constants of ternary complex formation.
Interaction kTa (mol
 1 mm2 s 1)* kTd (s
 1)* KTD (molecules lm
 2)
IL-4/IL-4Ra 2 IL-13Ra1 (3.8±1.0)  1015 0.23±0.04 36±15* 1.6±0.4w 0.1±0.1z
IL-13/IL-13Ra1 2 IL-4Ra (1.1±0.6)  1014 0.0023±0.0007 13±11* n.d. 0.4±0.2z
KFR/IL-4Ra 2 IL-13Ra1 — o0.002 o5* 0.3±0.1w 0.4±0.2z
RGA/IL-4Ra 2 IL-13Ra1 — 40.5 296±104* (45) 1.2±0.6z
*Molecular interactions determined with receptor ectodomains tethered onto SSMs.
wMolecular interactions determined with transmembrane receptor reconstituted into PSMs.
zEffective KTD estimated from single molecule dimerization assays in the plasma membrane of living cells.
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nearly tenfold increase in the KTD compared to
AT488IL-4D was
observed; by contrast, more than 30-fold more efficient ternary
complex formation compared to AT488IL-4D was found for
AT488KFRD. In the latter case, determination of KTD by this
technique was obstructed because the ligand dissociation kinetics
was too slow to be reliably analysed, which is in very good
agreement with the B400-fold increased binding affinity of KFR
versus IL-4 for IL-13Ra1 (ref. 34). By contrast, no significant
receptor dimerization was detectable for AT488DND (Fig. 1d), in
line with its dramatically reduced IL-13Ra1 binding affinity.
Analogous TIRFS experiments were carried out using OG488IL-13
(Fig. 1d and Supplementary Fig. 5D), for which the opposite
sequence of subunit binding is assumed (Fig. 1a, bottom). For the
interaction of IL-13Ra1-EC/IL-13 with IL-4Ra-EC a KTD of
(13±11) molecules per mm2 was obtained, suggesting a
somewhat more efficient ternary complex formation as for
IL-4D. Taken together, these in vitro experiments confirmed
that the molecular 2D dimerization affinities are scaling with 3D
binding affinities determined for different agonists.
2D complex stabilities correlate with binding affinities.
Different binding affinities towards the receptor subunits are
accompanied by changes in the interaction kinetics, which has
important implications for the formation and the lifetime of
individual complexes. We employed chasing experiments in
combination with Förster resonance energy transfer (FRET) to
quantify the two-dimensional dissociation kinetics of receptor
dimers at the membrane39,40. For this purpose, IL-13Ra1-EC
site-specifically labelled with Alexa Fluor 568 via an N-terminal
ybbR-tag (AF568IL-13Ra1-EC) and IL-4 carrying an acceptor
fluorophore (DY647IL-4) were used to monitor the dissociation of
IL-13Ra1 from IL-4/IL-4Ra in the plane of the membrane as
depicted in Fig. 2a. For these experiments, the K84D mutation of
IL-4 was not required as the 2D dissociation was probed and
ligand dissociation from IL-4Ra was not necessary. After
formation of the ternary IL-4Ra-EC/DY647IL-4/AF568IL-13Ra1-
EC complex at approximately stoichiometric amounts, a large
excess of IL-4Ra-EC (B10-fold) was tethered onto the
membrane. By injecting unlabelled IL-4, which very rapidly and
tightly binds to the free IL-4Ra-EC, exchange of labelled
versus unlabelled IL-4 in ternary complex with IL-4Ra-EC and
AF568IL-13Ra1-EC was initiated. The kinetics of this process
is limited by the 2D dissociation of DY647IL-4/IL-4Ra from
AF568IL-13Ra1-EC, which was monitored by a decay in FRET
efficiency that could be observed in both the donor and the
acceptor channel (Fig. 2a, dashed rectangle). Comparison of the
mass signal for IL-4 binding to the surface and the recovery of the
donor fluorescence confirmed that the 2D dissociation of the
ternary complex could be quantified by this method (Fig. 2b),
yielding a 2D dissociation rate constant kTd of (0.23±0.04) s
 1.
In case of DY647RGA, significantly faster dissociation of the
ternary complex was observed, which could not be temporally
resolved by this assay (Fig. 2c and Supplementary Fig. 8). In
contrast, a more than tenfold decreased kTd was estimated for
DY647KFR (Fig. 2c and Supplementary Fig. 9), in line with its
increased IL-13Ra1 binding affinity. We also quantified the
stability of the IL-13Ra1-EC/IL-13 interaction with IL-4Ra-EC—
the interaction predicted to determine the lifetime of ternary
complexes formed by IL-13. Since IL-13 exhibits a tenfold faster
dissociation from binary than from ternary complexes, the 2D
dissociation rate constant kTd could be quantified by fitting
the ligand dissociation kinetics of an appropriate ligand
chasing experiment (Supplementary Fig. 10)40. The kTd of
(0.0023±0.0007) s 1 obtained for this interaction (IL-13Ra1-
EC/IL-132IL-4Ra-EC) is similar as the estimated kTd of the
IL-4Ra-EC/KFR2IL-13Ra1-EC complex, while the 2D
association rate constant is more than 30-fold lower compared
to IL-4 (Table 1).
Enhanced dimerization of the transmembrane receptor. These
measurements yielded a comprehensive quantitative picture of
the molecular interactions between the ligand and the receptor
ectodomains involved in the assembly of the type II IL-4 receptor
on membranes (summarized in Table 1 and Supplementary
Fig. 11). The absolute KTD values obtained for the different
agonists predict substantial differences in IL-4Ra/IL-13Ra1
dimerization at the cell surface concentrations of endogenous
receptors, which typically are below 1 molecule per mm2 (ref. 25).
However, the contribution of the transmembrane domain in
receptor dimerization was neglected by this assay. We therefore
quantified, by single molecule fluorescence imaging, the
dimerization of transmembrane IL-4Ra and IL-13Ra1
reconstituted into polymer-supported membranes (PSMs) at
physiologically representative densities. For this purpose, IL-4Ra
and IL-13Ra1 fused to an N-terminal SNAPf-tag41 and truncated
C-terminally after the transmembrane helix were produced in
HEK 293T cells. After labelling of the SNAPf-tag by addition of
BG-DY547 and BG-DY647, respectively, the receptor subunits
(DY547IL-4Ra-TM and DY647IL-13Ra1-TM, respectively) were
affinity-purified from the detergent-solubilized membrane
fraction and transferred into PSMs as described recently42.
Dual-colour total internal reflection fluorescence (TIRF)
microscopy was applied for imaging diffusion and interaction
of DY547IL-4Ra-TM and DY647IL-13Ra1-TM at single molecule
level (Supplementary Fig. 12A). Receptor dimerization
at different concentrations of IL-4, KFR and RGA, respectively,
was quantified by single molecule co-localization and co-tracking
analyses (Supplementary Movie 1 and Fig. 3)42. These
experiments confirmed ligand-induced dimerization of the
transmembrane receptor as well as the critical role of the
affinity to IL-13Ra1 in receptor dimerization: while strong
dimerization by KFR was achieved, dimerization by RGA was
just above the significance threshold (Fig. 3). By contrast, the
reduced IL-4Ra affinity of IL-4D only shifted the maximum of the
curve to a higher ligand concentration, while the amplitude
remained unaffected (Fig. 3). These observations corroborated the
relevance of 2D binding affinities for receptor dimerization at
physiological receptor densities that cannot be compensated by
increasing the ligand concentration. By fitting a comprehensive
binding model (Supplementary Fig. 12B) to the concentration-
dependent dimerization curves, KTD values for the transmembrane
receptor were determined. Strikingly, the KTD obtained under
these conditions were 10-20-fold lower compared to the
membrane-tethered receptors (Table 1), suggesting that either
the receptor orientation or potential interactions imposed by the
transmembrane domains contribute to receptor dimerization.
Similar mobility and STAT6 activation by all IL-4 agonists.
The molecular properties governing receptor assembly confirmed
a broad spectrum of 2D binding affinities and rate constants
suitable for a systematic correlation with receptor assembly and
activation in living cells. At first, the interaction of IL-4 variants
and IL-13 site-specifically labelled with DY647 (DY647IL-4 and
DY647IL-13) with the endogenous cell surface receptor was
employed for exploring the spatiotemporal organization of
signalling complexes in the plasma membrane under physiolo-
gical conditions by single molecule imaging techniques. Using
PEGylated glass coverslips23, highly specific ligand binding to the
surface of HeLa cells, which were confirmed to express IL-4Ra
and IL-13Ra1, but not gc (Supplementary Fig. 13), was observed
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by TIRF microscopy at single molecule level (Supplementary
Movie 2 and Fig. 4a,b). Individual ligands diffusing in the plasma
membrane could be discerned as confirmed by single step
photobleaching at elevated laser power. Under saturating ligand
concentrations (2 nM), similar densities of receptor complexes
(0.06–0.08 mm 2) were observed for DY647IL-4 and its variants
DY647KFR, DY647RGA and DY647DN as well as for DY647IL-13
(Fig. 4b). No tendency of clustering was observed, but stochastic
distribution and random diffusion in the plasma membrane.
Under these conditions, individual ligands could be readily
tracked with high fidelity (Supplementary Movie 2 and Fig. 4a)
and their diffusion properties could be quantified by evaluating
the trajectories. Mean square displacement analysis confirmed
random diffusion of signalling complexes in the plasma
membrane (Supplementary Fig. 14A). Typically, B25% of the
tracked molecules were immobile, which can in part be ascribed
to non-specific adsorption to the coverslip surface as well as to
complexes involved in endocytosis. For this reason, the immobile
fraction was removed from the data set before further analyses
to ensure that only ligands bound to the cell surface were
considered. Diffusion constants obtained from step-length
histograms (Fig. 4c,d; Table 2 and Supplementary Fig. 14B)
revealed a significantly reduced mobility of DY647KFR compared
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Figure 2 | Quantification of the ternary complex 2D dissociation kinetics on SSMs by FRET. (a) Typical assay as monitored by TIRFS-RIf (cartoon
depicted at the top): after sequentially tethering (1) IL-4Ra-EC (100 nM) and (2) AF568IL-13Ra1-EC (150 nM, FRET donor) onto a SSM, (3) DY647IL-4
(100 nM, FRET acceptor) was injected to form a ternary complex in an approximate 1:1:1 stoichiometry. The AF568 fluorescence (orange curve) decreases
during DY647IL-4 binding due to FRET from AF568IL-13Ra1-EC upon ternary complex formation, while in turn the DY647 fluorescence (red curve) increases
(dotted rectangle). After washing out unbound ligand, (4) a large amount of IL-4Ra-EC (1 mM) is tethered onto the membrane prior to (5) fast chasing with
unlabelled IL-4 (1 mM) that rapidly occupies all excess IL-4Ra-EC on the membrane. Thus, a 2D exchange of DY647IL-4/IL-4Ra-EC bound to AF568IL-13Ra1-
EC by IL-4/IL-4Ra-EC is initiated, which is accompanied by recovery of the donor fluorescence with a rate constant corresponding to kTd . RIf signal is shown
in black. (b) The 2D dissociation rate constant kTd was obtained by fitting an exponential function (black line) to the AF568 signal (orange points) within the
time window highlighted in a. The RIf signal of IL-4 binding to excess IL-4Ra-EC (black points and dashed line) is shown to indicate the time resolution of
this assay. (c) Comparison of the donor fluorescence recovery (that is, dissociation kinetics) obtained for DY647RGA (orange), DY647IL-4 (violet) and





























Figure 3 | Dimerization of the transmembrane receptor reconstituted
into PSM. Single molecule co-localization of DY547IL-4Ra-TM and DY647IL-
13Ra1-TM reconstituted into PSMs at different concentrations of IL-4, IL-4D,
KFR and RGA, respectively (mean±s.d. of 3–5 measurements). The lines
are best fits of a comprehensive equilibrium model (cf. Supplementary
Fig. 12B).
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supposedly interacts with IL-4Ra only, these results suggest that a
loss in receptor mobility is caused by ligand-induced receptor
dimerization. Similar changes in the diffusion properties have
been observed for ligand-induced dimerization of the type I
interferon receptor23. Interestingly, comparable mobility as for
KFR was observed for all IL-4 variants (except DN) and IL-13
(Table 2), indicating a similar ability to form signalling complexes
in the plasma membrane. In line with these experiments, ligand-
induced STAT6 phosphorylation examined by phospho-flow
cytometry showed largely overlapping potencies (Fig. 4e) and
similar kinetics (Fig. 4f) of STAT6 activation for all IL-4 variants,
with only a minor increase in potency observed for KFR. In
contrast, significantly lower potency of IL-13 and slower
signalling kinetics compared to the IL-4 variants were observed,
which could be related to the substantially lower on-rate that has
been shown to be an important determinant for signalling
potency25. These results suggest efficient receptor assembly by
different IL-4 variants irrespective of the large differences in
IL-13Ra1 binding affinity, hinting towards a spatiotemporal
organization of IL-4Ra and IL-13Ra1 in the cellular context.
Randomly diffusing receptor subunits are dimerized by IL-4.
To identify the cellular determinants of receptor dimerization we
visualized the receptor subunits in the plasma membrane by
dual colour single molecule fluorescence imaging for spatio-
temporal correlation of both receptor subunits (Supplementary
Fig. 15A–C)25. For this purpose, IL-4Ra fused to the SNAPf-tag
and IL-13Ra1 fused to the HaloTag43 were transiently
co-expressed in HeLa cells. These tags are engineered enzymes
that irreversibly react with their substrates, which is exploited
for orthogonal covalent labelling with photostable synthetic
fluorescent dyes. Posttranslational labelling was carried
out prior to imaging experiments by addition of the substrates
BG-DY647 (DY647IL-4Ra) and HTL-TMR (TMRIL-13Ra1),
respectively (Fig. 5a). After washing out excess dye, individual
DY647IL-4Ra and TMRIL-13Ra1 could be discerned at a B5–10-
fold elevated density compared to the endogenous receptor
(0.1–0.5 mm 2, Supplementary Fig. 15D). Single molecule
tracking confirmed random diffusion of both receptor subunits
(Supplementary Fig. 14A) with similar diffusion properties as
observed for DN bound to the endogenous receptor (Table 2).
Likewise, a similar level of typically 25% immobile molecules was
observed which was excluded from further analyses. Receptor




























































































































Figure 4 | Cellular binding and activity of different IL-4 agonists and IL-13. (a) Live-cell single molecule localization and tracking of DY647KFR bound to
endogenous cell surface IL-4Ra and IL-13Ra1 of a HeLa cell. The underlying cell is indicated by the grey background; single molecule trajectories are
depicted as red lines (see also Supplementary Movie 2). Scale bar: 10mm. (b) Cell surface density of bound IL-4 variants and IL-13 quantified by single
molecule localization. As negative control, binding of DY647IL-4 after preincubation with 20 nM unlabelled KFR was quantified. (nZ10 cells for IL-13, IL-4,
RGA and KFR, n¼ 5 cells for DN and ctrl.) (c) Diffusion properties of cell-bound DY647DN (blue) and DY647KFR (green) presented as step-length
distributions, which were fitted (dashed lines) by considering two components corresponding to a slow and a fast mobile fraction. Shift to lower mobility by
KFR indicates ternary complex formation in contrast to DN, which does not interact with IL-13Ra1. (d) Comparison of the step-length histograms for
DY647IL-13, DY647IL-4, DY647RGA, DY647KFR and DY647DN. Fitted curves in c,d are based on data from n4350 single-molecule trajectories (n¼ 200 for
DN) with minimum length of 150 frames. Individual step lengths were determined for a time lapse of 32 ms (1 frame) and histogramed as depicted in
Supplementary Fig. 14B. (e,f) STAT6 phosphorylation activity of different agonists in HeLa cells analysed by phospho-flow cytometry. (e) Dose–response
curves of STAT6 phosphorylation observed after stimulation for 15 min. (f) Kinetics of STAT6 phosphorylation after stimulation with 1 mM of agonist. Data
points in e,f represent mean±s.d. of three independent experiments.
Table 2 | Average diffusion constants obtained from single
molecule tracking data (mean±s.d.).
Ligand D (lm2 s 1)
DN (primarily binary complex) 0.113±0.002*




IL-4Ra (w/o ligand) 0.119±0.010w
IL-4Ra (w/ KFR) 0.107±0.002w
IL-13Ra1 (w/o ligand) 0.140±0.012w
IL-13Ra1 (w/KFR) 0.108±0.001w
IL-4Ra/IL-13Ra1 dimers (ligand induced) 0.087±0.003z
*Obtained with DY647-labelled ligands bound to the endogenous receptor.
wMean values determined in cells co-expressing IL-4Ra and IL-13Ra1 without ligand and after
addition of KFR.
zMean values from DY647IL-4Ra/TMRIL-13Ra1 co-trajectories in presence of either IL-4, IL-13 or
KFR.
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tracking23 (Supplementary Fig. 15B and Fig. 5a,b). Co-tracking of
DY647IL-4Ra and TMRIL-13Ra1 in absence of ligand did not yield
any indication of receptor pre-dimerization (Fig. 5c). Upon
addition of IL-4, however, individual DY647IL-4Ra/TMRIL-13Ra1
dimers diffusing in the plasma membrane could be clearly
identified and tracked for several seconds (Supplementary
Movie 3 and Fig. 5a–c). Such dimers could be observed for
all ligands, yielding similar diffusion properties (Table 2).
A small, yet significant reduction in mobility of DY647IL-4Ra
and TMRIL-13Ra1 upon ligand-induced dimerization was noticed
(Fig. 5d and Table 2), yielding a diffusion constant matching the
diffusion constant obtained for DY647KFR bound to endogenous
receptor (Table 2). These results clearly confirmed the hypothesis
of ligand-induced receptor dimerization in the plasma membrane
and suggest a surprisingly high dimerization efficiency for all
ligands.
Efficient receptor dimerization by all ligands. To quantify the
spatial receptor organization and dimerization in the plasma
membrane more precisely, we employed particle image cross-
correlation (PICCS) analysis44 at the single molecule level. PICCS
directly quantifies the spatial correlation of two spectrally
separated molecule species via a cross-correlation function
Ccum that was calculated from all molecule positions of a single
cell as schematically depicted in the inset of Fig. 6a and in
Supplementary Fig. 15C. By fitting the linear component of Ccum
with equation (1), the correlated fraction a as a measure for
non-random co-localization is obtained from the intercept. In
absence of ligand, individual DY647IL-4Ra and TMRIL-13Ra1
molecules did not show any significant a (Fig. 6a), confirming
that the receptor subunits are neither pre-dimerized nor
pre-organized in the plasma membrane. Instead, the entirely
linear shape of the Ccum indicates a random receptor distribution
in the plasma membrane. After incubating IL-4 at a concentration
saturating all IL-4Ra subunits, dimerization could clearly be
identified as an increase of a to B11% (Fig. 6b,c). For converting
a into absolute dimerization levels, a reliable determination of the
degree of receptor labelling is required, which was obstructed by
the substantial receptor turnover after cell surface labelling,
probably caused by rapid, ligand-independent endocytosis of the
IL-4 receptor45. Taking advantage of the highly asymmetric
binding affinities of IL-4 towards the receptor subunits, we
therefore used labelled IL-4 to directly quantify the fraction of
IL-4Ra-bound IL-4 forming a ternary complex with IL-13Ra1.
For this purpose, the interaction of DY647IL-4 with TMRIL-4Ra
c
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Figure 5 | Receptor dimerization probed by single molecule co-tracking analysis. (a) Co-tracking assay: IL-4Ra (green) was fused to the SNAPf-tag and
labelled with BG-DY647 while IL-13Ra1 (magenta) was fused to the HaloTag and labelled with HTL-TMR. Individual co-localized DY647IL-4Ra and TMRIL-
13Ra1 (white signal highlighted by the arrow) in presence of IL-4 was co-tracked over 500 frames (16 s, cf. Supplementary Movie 3). The corresponding
trajectory is depicted as a red line. Scale bar: 2 mm. (b) Distance between the two molecules in each frame. (c) Co-tracking analysis of DY647IL-4Ra and
TMRIL-13Ra1 in the absence and in the presence of IL-4. Scale bar: 5 mm. (d) Diffusion properties of DY647IL-4Ra and TMRIL-13Ra1 before and after
stimulation with 200 nM KFR as well as of ligand induced DY647IL-4Ra/TMRIL-13Ra1 dimers presented as fitted step-length distributions (time lapse 32 ms,
1 frame), based on two components corresponding to a slow and a fast mobile fraction. Depicted curves are based on data of a representative single cell
experiment comprising n4400 trajectories (n¼ 24 for dimers) with min. length of ten frames.
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and with TMRIL-13Ra1, respectively, was quantified by PICCS in
separate experiments (Fig. 6d). A cross-correlated fraction of
B18% was observed for the DY647IL-4/TMRIL-13Ra1 interaction
compared to B28% for the DY647IL-4/TMRIL-4Ra complex.
These results implicate that 60–70% of IL-4Ra bound to IL-4 on
the cell surface forms a ternary complex with IL-13Ra1. Taking
into account the average cell surface concentrations of DY647IL-
4Ra and TMRIL-13Ra1 quantified by single molecule localization
and corrected for the degree of labelling, an effective KTD of B0.1
molecules per mm2 was estimated for IL-13Ra1 interacting with
the IL-4Ra/IL-4 complex. Thus, receptor dimerization in the
plasma membrane is 410-fold more efficient compared to the
molecular interaction in artificial membranes.
Only minor differences in the dimerization efficiencies were
observed for the IL-4 mutants as well as for IL-13 (Fig. 6c,
Supplementary Table 4), despite the very large differences in the
molecular interactions observed in vitro. While the increase in
IL-13Ra1 binding affinity of the KFR mutant did not yield
any increase in dimerization efficiency, only a small, yet
significant drop in dimerization efficiency was observed for
RGA. Even for the variant DN with immeasurable binding
affinity to IL-13Ra1, receptor dimerization above the background
could be detected, in line with its residual STAT6 phosphoryla-
tion activity (Fig. 4e,f). In contrast, the dimerization efficiency of
IL-13 turned out to be lower compared to IL-4, despite the overall
higher KTD of IL-4 observed in vitro. The apparently reduced
dimerization efficiency of IL-13, however, could be explained by
the B20% excess of IL-13Ra1 used in these experiments. Taken
together, these quantitative dimerization assays substantiate that
ligand-induced dimerization of IL-4Ra and IL-13Ra1 in the
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Figure 6 | Quantification of ternary complex assembly in living cells. (a,b) Spatial correlation of TMRIL-13Ra1 and DY647IL-4Ra molecules for a
representative single cell in absence (a) and presence (b) of IL-4, analysed by PICCS. Black circles: cumulative correlation function Ccum obtained from
single molecule localizations, averaged over frames 1–20. Dashed green line: linear contribution of the cumulative correlation function (equation (1)).
Orange dashed line: cumulative correlation function after subtraction of the linear term from the fitted function (equation (2), red curve). (c) Correlated
fraction of TMRIL-13Ra1 and DY647IL-4Ra for the examined ligands, determined by PICCS. (d) Quantification of receptor dimerization by PICCS analysis
of DY647IL-4 bound to TMRIL-4Ra and to TMRIL-13Ra1, respectively. Data are based on n¼ 16 cells (IL-13Ra1þ IL-4) and n¼ 9 cells (IL-4Raþ IL-4).
(e) The correlation length (s) obtained from PICCS analysis. The data shown in c,e are pooled from at least two independent experiments with n420 cells
(n¼9 cells for unstim. and n¼6 cells for DN and pos. ctrl.). (f) Receptor distance distributions of co-trajectories, induced by KFR, IL-4, IL-13 and RGA,
fitted with a three-component log-normal function. Depicted curves are based on data from different cells comprising n450 trajectories with minimum
length of 30 frames. Statistical analysis by a two-sample Kolmogorov–Smirnov test (*Po0.05).
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Increased inter-subunit distance for weak 2D interactions.
Plasma membrane microcompartmentation plays an intricate role
in the spatiotemporal organization of signalling complexes46–51
and has been proposed to support receptor dimerization and
activation by increasing the local concentration of interaction
partners or by stabilizing signalling complexes46,48. Since PICCS
analysis excluded pre-organization of the receptor subunits in the
absence of ligand we explored in more detail the spatiotemporal
dynamics of receptor dimers after ligand stimulation. For this
purpose, we compared, for the different ligands, the correlation
length s obtained from fitting Ccum with equation (2), which
corresponds to the average distance of spatially correlated receptor
subunits (Fig. 6e and Supplementary Table 4). Assuming that only
DY647IL-4Ra and TMRIL-13Ra1 dimerized by the ligand contribute
to a, a theoretical s of B10 nm is expected based on the distance in
the crystal structure of the ternary complex26. The experimental
s of B60 nm observed in a positive control protein with both
SNAPf-tag and HaloTag fused to a transmembrane domain
(Fig. 6e) can be ascribed to the limited overall precision of single
molecule co-localization. This not only includes the photon-based
localization precision and the precision of channel alignment, but
also blurring due to the movement of the proteins during imaging.
While DY647IL-4Ra and TMRIL-13Ra1 dimers induced by IL-4,
KFR and IL-13 show s values similar to the positive control
(70–90 nm), a significantly increased s (140 nm) was observed in
case of RGA. The increased average distance of DY647IL-4Ra and
TMRIL-13Ra1 in complex with RGA was accompanied by an
increased bandwidth of s. This finding was corroborated by
directly quantifying the distances in individual DY647IL-4Ra/
TMRIL-13Ra1 dimers identified by dual colour single molecule
co-tracking analysis (Fig. 6f). Compared to all other ligands, a
substantial shift to higher distances was observed for RGA-induced
dimers including a significant fraction of distances above the
co-localization precision (Fig. 6f, Supplementary Fig. 16 and
Supplementary Table 5).
Dimer lifetime depends on the cortical actin skeleton. We
hypothesized that this increased inter-subunit distance observed
for RGA was caused by transient 2D dissociation from IL-13Ra1
followed by rapid re-association due to trapping within sub-
microscopic transient confinement zones (TCZ)46,47,52.
Assuming TCZ dimensions o100 nm as reported for diffusion
in the plasma membrane46, such transient dissociation events
could not be resolved by the spatiotemporal resolution of the
experimental setup used for single molecule co-tracking and
therefore apparently enhanced complex stability would be
expected. We therefore quantified the lifetime of individual
receptor dimers by dual colour single molecule tracking. To
directly probe the low-affinity interaction of IL-4Ra/IL-4 with
IL-13Ra1, we expressed, by means of an inducible promoter53,
HaloTag-IL-13Ra1 at physiological levels in HeLa cells. After
labelling of HaloTag-IL-13Ra1 with HTL-TMR, DY647KFR or
DY647RGA was added at a concentration sufficient to rapidly bind
and saturate endogenous IL-4Ra. Because in vitro labelling of IL-
4 is achieved with a yield 490%, dimerized receptor subunits
could be well detected at these low concentrations, while co-
tracking of DY647KFR or DY647RGA and TMRIL-13Ra1 was
possible with high fidelity. The distribution of co-trajectory
lengths’ was taken as a semi-quantitative measure for the complex
stability. Very similar patterns were obtained for KFR and RGA
(Fig. 7a, left), despite the more than 100-fold faster dissociation of
RGA from IL-13Ra1 observed on SSMs. While the experimental
trajectory length is limited by photobleaching and tracking
fidelity, a significant lower complex stability (o1 s) of receptor
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Figure 7 | Dynamic complex stabilization by the actin cytoskeleton. (a) Co-trajectory length of RGA-induced ternary complexes is dramatically decreased
due to disruption of the actin cytoskeleton by LatB (Latrunculin B) treatment. Data are based on n460 ( LatB) and n417 (þ LatB) cells. Co-trajectories
with less than 30 frames were not considered. (b) Diffusion constants of fluorescent ligand-bound receptors in absence and in presence of LatB
(mean±s.d. of n410 cells). (c) Maximum relative pSTAT6 level in presence of LatB is distinctly lowered for RGA. HeLa cells were treated with 10mm LatB,
stimulated for 15 min with saturating doses of the respective ligand and the relative levels of pSTAT6 compared to untreated cells were analysed by
phospho-flow cytometry using anti-pSTAT6 specific antibodies coupled to fluorescent dyes. Error bars correspond to the s.d. from three independent
experiments. Statistical analysis by Student’s t-test (*Po0.05). (d) DY647IL-4Ra (green) and TMRIL-13Ra1 (magenta) complex re-association at single
molecule level in presence of RGA. Images showing the complex at different time points of a 330-frame (10.6 s) time-lapse experiment (cf. Supplementary
Movie 4) including its corresponding co-trajectory (white). Scale bar: 1 mm. (e) Distance between the two molecules throughout the entire trajectory.
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These results supported our hypothesis of complex
re-association in submicroscopic TCZ, which were probably
caused by the cortical membrane skeleton (MSK)46. The MSK of
HeLa cells has been reported to have an average mesh size of
B70 nm with a typical residence time of B5 ms (refs 54,55). To
explore the role of the MSK in receptor diffusion and interaction
we applied Latrunculin B (LatB), a compound that partially
inhibits actin polymerization by binding to monomeric G-actin56
and thus decreases confinement by the MSK55,57. For a minimum
bias of other cellular functions, a concentration of LatB was
applied (10 mM), which was optimized to dissipate the fine
cortical actin structure while major stress fibres and the cell
morphology was maintained (Supplementary Fig. 17). Under
these conditions, the diffusion constants of IL-4Ra and IL-13Ra1
increased (Fig. 7b), as expected for MSK-limited hop diffusion in
the plasma membrane55,58,59. By contrast, no significant changes
in the diffusion properties of the receptor could be observed
upon treatment with cholesterol oxidase (Supplementary Fig. 18),
which has been shown to affect the mobility of lipid
raft-associated proteins60. These results established that
microcompartmentation by the MSK is the major determinant
of type II IL-4 receptor spatiotemporal dynamics in the plasma
membrane.
We therefore explored the contribution of the MSK that has
been recently proposed to promote re-association of receptor
dimers47,49,52. Strikingly, LatB treatment substantially reduced
the length of co-trajectories of receptor dimers induced by RGA,
but not by KFR (Fig. 7a, right). The mobility of RGA- and
KFR-induced dimers, however, was identical after LatB treatment
(Supplementary Fig. 19). The importance of MSK-dependent
receptor confinement was further supported by the differences in
overall mobility observed for IL-4 and mutants in presence of
LatB (Fig. 7b): the largest increase was observed for RGA, in line
with its higher propensity to exist bound to IL-4Ra only. These
results sustained our hypothesis that submicroscopic TCZ
based on the MSK support receptor dimerization by RGA.
To investigate the functional relevance of this feature for
downstream signalling we quantified the maximum level of
STAT6 phosphorylation induced by different agonists in presence
of LatB using phospho-flow cytometry. While all ligands showed
reduced pSTAT6 activation in presence of LatB, this effect was most
pronounced for RGA (Fig. 7c). These results established that the
low molecular affinity of RGA can be at least partially compensated
by ensuring efficient re-association in MSK-based TCZ.
A simple spatial-stochastic model mimics receptor dynamics.
These results confirmed that MSK-dependent TCZ were involved
in dynamically stabilizing transient receptor dimers, probably by
ensuring efficient re-association of dissociated complexes.
For some trajectories, dissociation of receptor dimers and
re-association of the same subunits could even be followed with
the spatiotemporal resolution of our setup (Supplementary Movie
4 and Fig. 7d,e), corroborating the relevance of this process under
physiological conditions. To validate this conclusion, we estab-
lished a simple spatial diffusion-reaction model including a
submicroscopic, semipermeable meshwork (Supplementary
Movie 5 and Supplementary Fig. 20) as proposed by the MSK
concept54. The molecular dissociation probabilities and local
diffusion properties were parameterized as quantified in vitro. By
adjusting the hopping and association probabilities, diffusion
properties of the receptor subunits and the ternary complex as
well as total receptor levels in complex could be closely matched
with the experimentally obtained data (Supplementary Movie 6
and Supplementary Fig. 21A–E). Under these conditions, a
slightly increased probability (þ 10%) of molecule collision
compared to a fully homogenous diffusion scenario was
observed (data not shown), which is caused by the meshwork
constraints. The number of re-associations after dissociation of
receptor dimers, however, is increased by 125% due to the
membrane confinement and the re-association frequency is, as
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Figure 8 | Simulation of spatiotemporal receptor dynamics including MSK-dependent membrane compartmentation and hop-diffusion.
(a) Representative receptor distance distributions of co-trajectories as well as (b) the corresponding correlation lengths, simulated on the basis of the
depicted model depicted in Supplementary Fig. 20 with two different ternary complex dissociation constants (n¼ 5) are comparable to the experimentally
derived data and verify the adopted model. (c) The mean ternary complex lifetime is increased by B50% in simulation runs including confinement by the
MSK (mean±s.d., n¼ 10). (d) Mechanistic model for ligand-induced type II interleukin-4 receptor dimerization sustained by rapid re-association within
MSK-dependent TCZ. After two-step receptor assembly of the ternary complex (I), downstream signalling is initiated (II) that is maintained during
transient dissociation events (III, IV) until receptor uptake by endocytosis (V).
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(Supplementary Fig. 21F). Importantly, the receptor distance
distributions of co-trajectories as well as the corresponding
correlation lengths extracted from simulation runs with different
ternary complex dissociation constants are comparable to the
experimentally derived data and reproduce the shift to longer
distances/correlation lengths and broader distribution for a low-
affinity ligand (like RGA) (Fig. 8a,b) as experimentally observed
(Fig. 6e,f). Finally, similar to the negative effect of LatB on the
length of RGA-induced co-trajectories (Fig. 7a), our model
simulations revealed a B50% increased mean ternary complex
lifetime (measured as the time both receptor subunits reside in
the same compartment after undergoing at least one association
event) when comparing simulations with and without
constrained diffusion by the MSK (Fig. 8c and Supplementary
Fig. 21G,H). This effect was essentially independent on the
molecular complex lifetime (Fig. 8c), highlighting that the
re-association probability depends on the 2D association
kinetics52, which was assumed identical for both cases. Owing
to the relatively short observation times and limiting co-tracking
fidelity, the effect was experimentally most prominent for the
short-lived dimers formed by RGA.
Discussion
With its critical implication in allergy, asthma and cancer, the
type II IL-4 receptor is an important drug target28,29. For efficient
pharmaceutical targeting of receptor activation, detailed
understanding of its mode of engagement by the ligand is
desired, which is, however, controversially debated. Focusing on
the early events of ligand interaction with the receptor subunits in
the plasma membrane, we have here untangled the molecular and
cellular determinants governing assembly of the type II IL-4
receptor signalling complex. The 2D interactions involved in
receptor dimerization at the membrane were quantified by
in vitro assays with the ectodomains tethered onto SSMs as well
as with the transmembrane receptor reconstituted into PSMs.
These measurements confirmed ligand-induced receptor
dimerization and very different abilities of IL-4 mutants to
recruit IL-13Ra1 into the ternary complex. The KTD and k
T
d values
of the 2D ligand–receptor interactions limiting receptor
dimerization were in line with the relative binding affinities of
the different ligands. Yet, all ligands showed substantially
enhanced dimerization of the transmembrane receptor subunits
in PSMs compared to the KTD determined on SSMs, suggesting
that the transmembrane helix either structurally organizes the
receptor subunits in a favourable orientation on the membrane or
directly mediates contacts stabilizing the complex. The molecular
basis of this striking contribution of the transmembrane domain
for ligand-induced receptor dimerization needs to be investigated
in more detail in the future.
Although strong differences in dimerization of transmembrane
IL-4Ra and IL-13Ra1 in PSMs was observed for different IL-4
variants, their functional properties in living cells in terms of
receptor binding, diffusion and early signal activation proved to
be very similar, suggesting that spatial co-organization may
promote dimerization in the plasma membrane. Detailed single
molecule analyses, however, revealed random and uncorrelated
distribution of IL-4Ra and IL-13Ra1 in the plasma membrane,
yet very efficient dimerization by all ligands. The high degree of
ligand-induced receptor dimerization revealed by single molecule
imaging at physiological cell surface expression levels was in
agreement with previous estimations for the related type I IL-4
receptor based on competitive antibody binding experiments61.
By contrast, recent live cell fluorescence cross-correlation
spectroscopy studies30 suggested much less efficient
dimerization of the type II IL-4 receptor in the plasma
membrane. Importantly, substantially higher receptor densities
were required for these measurements (41,000-fold above the
endogenous cell surface expression level), which may account for
these fundamental differences. Indeed, our results indicate that
the cellular context may play an important role for ensuring
efficient receptor assembly, for example, by enhancing the local
subunit concentrations by partitioning into membrane
microdomains. However, co-organization or co-clustering of
receptor subunits in the absence of ligand, which has been
proposed for several cytokine receptors18–21, was excluded by
spatial correlation techniques. Receptor dimers did not exhibit
any tendency of partitioning at the plasma membrane either, but
diffused freely while showing only a minor loss of mobility upon
dimerization, which can be explained by the increased friction
upon assembly of receptor dimers. These observations support
that ligand-induced dimerization of receptor subunits randomly
distributed in the plasma membrane is the key event for
activation of cytokine receptors.
Detailed studies of the spatiotemporal dynamics of receptor
dimers revealed a critical role of MSK-based TCZ in dynamically
stabilizing transient receptor dimers. Such re-association events
have been predicted to enhance signalling by promoting
signalling bursts46,47 and recent fast quantum dot tracking has
supported their relevance for the kinetics of receptor
dimerization49,52. By a simple spatial-stochastic model fully
parameterized by experimentally derived constants, we could
reproduce essential features of the spatiotemporal receptor
dynamics in the plasma membrane. This model corroborates
the hypothesis that passive confinement by the MSK ensures
rapid re-association of transient receptor dimers. While
cholesterol depletion experiments suggest that lipid-based
segregation does not significantly contribute to receptor
dimerization, MSK-dependent hierarchical TCZ as observed by
recent single particle tracking studies with very high
spatiotemporal resolution49,52 may further enhance this effect
and thus explain the residual discrepancies between experimental
and simulated data. However, rather than shifting the equilibrium
by local enrichment of the interaction partners, MSK-based TCZs
ensure rapid re-association of the same receptor subunits. Thus,
the increased inter-subunit distances observed for RGA compared
to the other ligands correspond to transiently dissociated receptor
dimers, suggesting that quantification by single molecule co-
tracking analysis overestimates the fraction of receptor dimers.
Importantly, similar re-association in TCZ can also be expected
for the other ligands, but, due to the substantially higher
molecular complex stability, over substantially longer time-
scales that are beyond the time-scale of our single molecule
co-tracking experiments. Interestingly though, these transient
dissociation events do not seem to compromise signalling as the
potency of STAT6 activation by RGA is similar compared to the
other ligands. These results suggest that downstream signalling
may be maintained during transient dissociation events as
schematically depicted in Fig. 8d, which can be rationalized by
the very short lifetime of the dissociated state. Such a ‘kinetic
trapping’ of receptor dimers may even be more beneficial
considering that under physiologically relevant conditions
robust receptor activation is achieved at very low receptor
expression levels and sub-stoichiometric occupancies. Kinetic
trapping of activated receptor dimers could ensure endocytosis of
intact signalling complexes (cf. Fig. 8d), allowing to maintain
signalling activity in early endosomes as specifically demonstrated
for the IL-4 receptor25,31. Thus, rather than being relevant for
pre-organization of receptor subunits, our results support the
emerging role of plasma membrane microcompartmentalization
in sustaining signalling complexes, once they have formed, by
passive confinement47,52.
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There is growing evidence that the affinity and dynamics of
signalling complexes play a key role for functional selectivity and
pleiotropy of cytokines26,34,62–68. Here, we could show that the
spatiotemporal dynamics of the type II IL-4 receptor signalling
complex is governed by an intricate interplay of molecular
interactions and receptor confinement in plasma membrane
microcompartments, which probably is a generic feature of
cytokine receptor dimerization. The early events of receptor
dimerization and activation are further convolved by molecular
and cellular feedback mechanisms69 that in turn also critically
depend on the molecular interactions involved in receptor
assembly. Furthermore, maintaining receptor dimers by TCZs
may have important implications for regulating specificity of
cellular responses in different cell types that vary in the size and
permeability of the MSK meshwork54. Taken together, these
features yield temporal evolution of downstream signalling, gene
expression patterns and cellular decisions that intricately depend
on the molecular ligand–receptor interactions as well as the
cellular context, thus fundamentally accounting for functional
selectivity and pleiotropy of cytokine receptor signalling.
Methods
Plasmid constructs. IL-13 wt, all IL-4 variants and both receptor ectodomains
were fused to an N-terminal ybbR-tag (sequence DSLEFIASKLA) for site-specific
labelling by phosphopantetheinyl transfer37. Coding sequences for IL-4 variants
fused to the ybbR-tag were created by side-directed mutagenesis of the IL-4 H59Y
sequence that was obtained by gene synthesis, and cloned into the pET28b vector
(Novagen) for expression in Escherichia coli. Sequences coding for ybbR-tagged
IL-13 wt as well as tagless IL-13 wt and IL-4 variants were cloned into the
pAcGP67-A vector (BD Biosciences) in frame with an N-terminal gp67 signal
sequence and a C-terminal hexahistidine tag for expression in insect cells. For
production of IL-4Ra-EC and IL-13Ra1-EC in insect cells, a modified version of
the pBAC3 (Novagen) transfer vector was used, comprising a gp64 signal peptide
followed by the sequence AMVDSLEFIASKLAGS (which includes the ybbR-tag),
the respective receptor ectodomain, a PreScission protease cleavage site and a
decahistidine tag at the C-terminus.
pSems HaloTag-IL-13Ra1 and pSems SNAPf-IL-4Ra were generated by
inserting IL-13Ra1 and IL-4Ra, respectively, without the N-terminal signal
sequences into the pDisplay vector (Invitrogen) via BglII and PstI (IL-13Ra1)/XhoI
(IL-4Ra) restriction sites. Subsequently, genes coding for the HaloTag43 (Promega)
and SNAPf-tag41 (New England Biolabs), respectively, were inserted via the BglII
site. The constructs including the Igk signal sequence of the pDisplay vector were
transferred by restriction with EcoRI and XhoI into the pSEMS1-26m vector
(Covalys). To obtain the tetracycline inducible reporter plasmid pWHE655-neo
TREtight HaloTag-IL-13Ra1 the sequence of the HaloTag-IL-13Ra1 construct
including the N-terminal signal sequence of the pDisplay vector was inserted into
the pWHE655-neo TREtight vector53 (kindly provided by Christian Berens,
Erlangen) using pSems HaloTag-IL-13Ra1 as template.
IL-13Ra1 and IL-4Ra truncated after the transmembrane domain (IL-13Ra1-
TM and IL-4Ra-TM, respectively) were inserted via restriction with BglII and XhoI
into the vector pSEMS1-26m including the Igk signal sequence as well as an
N-terminal His10 and a SNAPf-tag42 to obtain pSems SNAPf-IL-13Ra1-TM and
pSems SNAPf-IL-4Ra-TM expression vectors, respectively.
Sequences of all primers used for cloning are provided in Supplementary
Table 6.
Protein production and labelling. The expression vectors for the ybbR-tagged IL-
4 proteins were transformed into E. coli Rosetta cells, which were grown at 37 C
and induced by 1 mM IPTG using standard protocols. Cells from 2 l cultures were
lysed by sonication and inclusion bodies were isolated by centrifugation. Inclusion
bodies were purified by extensive washing steps and unfolded protein was extracted
with 6 M guanidium hydrochloride including 5 mM b-mercaptoethanol. Refolding
was carried out by dialysis against phosphate buffered saline (PBS; 120 mM NaCl,
2 mM KCl, 3 mM NaH2PO4, 7 mM Na2HPO4, pH 7.0) using a volume 4200-times
greater than the sample volume. Refolded IL-4 variants were purified by cation
exchange chromatography utilizing High-Performance SP-Sepharose (HiTrap SP
HP 5 ml, GE Healthcare) employing a linear NaCl-gradient from 0 M to 1 M at pH
7.0 (20 mM phosphate buffer). Pooled fractions were further purified by SEC on a
HiLoad 16/60 Superdex 75 column (GE Healthcare) equilibrated with PBS
(pH 7.4).
The ectodomains of IL-13Ra1 and IL-4Ra, all IL-13 proteins as well as tagless
IL-4 wt, KFR and RGA were produced in insect cells using a baculovirus expression
system. Baculovirus stocks were prepared by transfection and amplification in Sf9
cells grown in SF900II media (Invitrogen). High Five (Hi5) suspension cells grown
in Insect-Xpress media (Lonza) were infected with the respective baculovirus at an
MOI of 1–10. Three to five days after infection, cell supernatants were collected
by centrifugation and the proteins were captured by nickel-nitrilotriacetic acid
(Ni-NTA) agarose affinity chromatography. Pooled fractions were purified by
SEC on a Superdex 200 column (GE Healthcare), and equilibrated in 10 mM
2(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (pH 7.2)
containing 150 mM NaCl. All protein were purified to 490% homogeneity as
confirmed by SDS-PAGE analysis.
Site-specific labelling of ybbR-tagged proteins was carried out by means of Sfp
phosphopantetheinyl transferase using self-made CoA-DY647, -Alexa Fluor 568,
-Atto 488 or -OregonGreen 488 (Invitrogen) conjugates according to published
protocols70. Typically, protein concentrations of 10–20 mM reacted. After labelling,
the proteins were purified by SEC on a HiLoad 10/300 Superdex 75 column
(GE Healthcare). A degree of labelling 490% was obtained as determined by
UV/Vis spectroscopy for all ybbR-tagged proteins.
Interaction kinetics by simultaneous TIRFS-RIf detection. Simultaneous TIRFS
and reflectance interference detection (RIf) were performed using a home-built
set-up including a flow system that has been previously described in detail35,71.
All experiments were performed at 25 C using HBS buffer (20 mM HEPES,
150 mM NaCl, pH 7.5), which was complemented with 30 mM imidazole to
minimize unspecific binding of ligands to free chelator lipids. After mounting a
freshly plasma-cleaned RIf transducer into the flow cell, an SSM was generated by
injection of small unilamellar vesicles, which were prepared by sonication of
250 mM 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC, Avanti Polar Lipids)
containing 1 mol% tris-nitrilo triacetic acid-steroyl-octadecylamine (tris-NTA-
SOA)36. The SSM was then sequentially washed with 500 mM imidazole, 250 mM
EDTA and 10 mM NiCl2. IL-4Ra-EC and IL-13Ra1-EC were injected at
concentrations of 10–50 nM to obtain surface concentrations of 1-5 fmol mm 2.
Subsequently, 500 nM decahistidine-tagged maltose binding protein was injected to
block excess tris-NTA lipids. After loading the receptors and maltose binding
protein to the membrane, 50-100 nM of the respective AT488IL-4D variant or
OG488IL-13 was injected. Concentrations and injection times used in different types
of experiments are provided in the legends of the figures. Dissociation of the
fluorescently labelled ligand from the surface was monitored during rinsing for
600 s with HBS at a flow rate of 10ml s 1. After each experiment, all attached
proteins were removed by injecting 500 mM imidazole in HBS to recover the
membrane for the next measurement and to check the integrity of the SSM. In
these experiments, the mutation H59Y was used for all IL-4 variants to eliminate
non-specific binding to the membrane via the complexed Ni(II)-ions observed for
IL-4 wt. Importantly, this mutation has no effect on interaction kinetics or activity
(cf. Supplementary Fig. 4A,B). Binary interactions were evaluated by a standard
pseudo first-order kinetic model using Biaevaluation 3.1 (Biacore). Dissociation
from the ternary complex was evaluated by numerical fitting of the differential
equations describing a two-step dissociation using Berkeley Madonna 8.3
(UCB, Berkeley, CA, USA). The validity of the utilized model was computationally
confirmed by differential equation-based simulations (Supplementary Fig. 22).
2D dissociation rate constants measured by FRET experiments were obtained by
fitting an exponential function using OriginPro 8.6 (OriginLab Corp.).
Reconstitution of receptor subunits in PSM. SNAPf-IL-13Ra1-TM and SNAPf-
IL-4Ra-TM were expressed in HEK 293T cells (DSMZ, ACC 635) transiently
transfected at 40% confluency with the respective constructs. A 10 cm dish grown
to full confluency for each construct was pelleted after a brief incubation with
50 mM EDTA and after two washing steps with PBS, the cells were homogenized in
500 ml of lysis buffer (25 mM HEPES pH 7.4, 0.5 ml Benzonase, 10ml protease
inhibitors and 20 mM of Triton-X100). After cell lysis, 800 nM of BG-647 or BG-
547 (New England Biolabs) was added to the lysis mixture of SNAPf-IL-13Ra1-TM
or SNAPf-IL-4Ra-TM, respectively, and the labelling mixture was incubated for
30 min at room temperature. The lysate was then cleared by ultra-centrifugation
(55.000g for 45 min at 4 C). Proteins were extracted from the supernatant by
addition of 50ml of Ni-NTA agarose. After washed and eluted with 60 ml buffer
(25 mM HEPES, 300 mM NaCl, 10/500 mM imidazole, 0.6 mM Triton-X100),
proteoliposomes were formed by mixing 5 mM of DOPC supplemented with
2 mol% 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS) in HBS containing
20 mM Triton-X100 with 0.5–1ml of the eluted protein solution, followed by a
detergent extraction by addition of a twofold excess of b-cyclodextrin over the
detergent and incubation for 5 min (ref. 72).
PSMs were assembled on glass coverslips, which were coated with diamino-
poly(ethylene glycol) and functionalized with palmitic acid73 and then mounted
into an incubation chamber for imaging experiments. Proteoliposomes
complemented with DOPC/DOPS liposomes without proteins to a final lipid
concentration of 250mM in HBS were incubated on the coverslip surface for
30 min. After washout of excess vesicles, vesicle rupture was induced by addition of
10% (w/v) PEG8000 in HBS, which was incubated for 15 min. The PSM was then
extensively washed with buffer to remove excess lipid material.
Dimerization of reconstituted DY547IL-4Ra-TM and DY647IL-13Ra1-TM was
quantified by dual colour single molecule TIRF microscopy as described below.
Ligand concentrations were increased starting from 10 pM up to 50 mM in
logarithmically equidistant steps. For each titration, a new PSM was assembled.
After equilibration for 5 min, dimerization was quantified by single molecule co-
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localization analysis (see below). The dimer fraction was corrected for random co-
localizations and for the effective degree of labelling (DOL) of DY647IL-13Ra1-TM
and DY547IL-4Ra-TM, which was determined by co-localization experiments with
DY647KFR (DOL¼ 0.95) bound to DY547IL-4Ra-TM reconstituted in a PSM.
Cell culture, transfection and live cell labelling. HeLa cells (DSMZ, ACC 57)
were cultivated at 37 C and 5% CO2 in MEM with Earle’s salts, stable glutamine
and phenol red (Biochrom AG, FG0325) supplemented with 10% fetal bovine
serum (FBS) (Biochrom AG, S0615), 1% non-essential amino acids (PAA labora-
tories GmbH M11003) and 1% HEPES (PAA laboratories GmbH) buffer without
addition of antibiotics. For microscopy experiments, 20 mm glass coverslips
(VWR) were coated with a poly-L-lysine-graft-(polyethylene glycol) (PLL-PEG)
copolymer functionalized with RGD74 to minimize the fluorescent background
arising from non-specifically absorbed dye molecules. Cells were plated on the
coverslips in 35 mm cell-culture dishes to a density of B50% confluence and
treated with Penicillin/Streptomycin.
Cells were transfected with plasmids coding for HaloTag-IL-13Ra1 and SNAPf-
IL-4Ra using calcium phosphate precipitation as described earlier75. Twelve hours
after transfection, cells were washed twice with PBS (PAA laboratories GmbH) and
fresh medium was added. Transiently transfected cells were typically used for
co-tracking and ternary complex quantification experiments 3–4 days after
transfection, when the receptor density was close to the endogenous level. Lower
expression of HaloTag-IL-13Ra1 was achieved by transient transfection of
pWHE655-neo TREtight HaloTag-IL-13Ra1 into HeLa-TET cells that are stably
transfected with regulator plasmid pWHE644. Expression was induced by
treatment with 10–25 ng ml 1 doxycycline for 24 h.
For imaging experiments, coverslips were mounted into custom-made
incubation chambers with a volume of 500 ml. HaloTag- and SNAPf-tag-carrying
receptor molecules were simultaneously labelled by incubating with 30 nM
HaloTag tetramethylrhodamine (TMR) ligand (HTL-TMR, Promega, G8252) and
80 nM of SNAP-Surface647 (BG647, New England Biolabs, S9159S) in culture
medium at 37 C for 15 min. After labelling, cells were washed five times with
pre-warmed PBS to remove unreacted dye. For inhibiting actin polymerization
cells were treated with 10mM Latrunculin B for 20 min after labelling at 37 C.
Cholesterol depletion was carried out by treatment with 20 U cholesterol oxidase
(ChOx) for 30 min at 37 C.
Single molecule TIRF microscopy. Single molecule imaging experiments were
carried out by TIRF microscopy with an inverted microscope (Olympus IX71)
equipped with a triple-line total internal reflection (TIR) illumination condenser
(Olympus) and a back-illuminated electron multiplying charge coupled device
(EMCCD) camera (Ixon DU897D, 512 512 pixel, Andor Technology). A  150
magnification objective with a numerical aperture of 1.45 (UAPO 150 /1.45
TIRFM, Olympus) was employed for TIR illumination of the samples. DY647-
labelled ligands were excited by a 642 nm laser diode (LuxX 642-140, Omicron) at
0.65 mW (power output after passage of the objective). Stacks of 1,000–2,000
frames were recorded with a time resolution of 32 ms per frame (31.25 Hz). For
dual-colour acquisition, DY547IL-13Ra1 or TMRIL-13Ra1 were excited by a 561 nm
diode-pumped solid state laser (CL-561-200, CrystaLaser) at 0.95 mW and
DY647IL-4Ra or DY647-labelled ligands were excited by a 642 nm laser diode
(LuxX 642-140, Omicron) at 0.65 mW. Fluorescence was detected using a spectral
image splitter (DualView, Optical Insight) that was equipped with a 640 DCXR
dichroic beam splitter (Chroma) in combination with bandpass filters for detection
of TMR (585/40, Semrock) and of DY647 (690/70, Chroma), projecting each
channel onto 512 256 pixels (cf. Supplementary Fig. 15A). Stacks of 300–500
images were acquired at 31.25 Hz (32 ms per frame).
Microscopy was performed at room temperature in phenol red-free medium
supplemented with an oxygen scavenger and a redox-active photoprotectant
consisting of 0.5 mg ml 1 glucose oxidase (Roche Applied Science), 0.04 mg ml 1
catalase, 4.5 mg ml 1 glucose, 1 mM ascorbic acid and 1 mM methyl viologene
(all Sigma-Aldrich) to prevent blinking of the DY647 fluorophore and to minimize
photobleaching of both dyes76. For ligand binding studies, the respective DY647-
labelled ligand was added to a final concentration of 2 nM for at least 5 min. After
five washing steps with PBS, microscopy medium was added and imaging was
started rapidly. Receptor dimerization was probed before and after incubating with
the respective ligand at a concentration of 20 nM for at least 5 min if not otherwise
stated. Images of the same coverslip were acquired up to 30 min post-stimulation to
reduce artefacts that may arise from cellular feedback mechanisms such as receptor
endocytosis or stress responses.
Single molecule analyses. Single molecule localization and tracking was carried
out using the multiple-target tracing algorithm77 implemented in the customized
software package ‘SLIMfast’ (kindly provided by Christian P. Richter) written in
MATLAB (The MathWorks) as described previously in detail13. A detection box of
9 9 pixels was applied and five deflation loops were performed to ensure the
reliable identification of all molecules. A maximum of three nearest neighbours
were analysed for recovering particle trajectories and a detection gap between
successive frames of three missing points was closed. The local diffusion coefficient
was calculated from the past ten frames to model the PDF for observed
displacements and the expected diffusion coefficient was set to an empirically
optimized value between 0.09 and 0.15 mm2 s 1 (local and expected diffusion
equally weighted). With the applied parameter set a sub-micrometer localization
precision (ØB25 nm) of single molecules was achieved. Immobile molecules
(unspecific immobilized dyes and endocytosed labelled receptors) were identified
by the ‘density-based spatial clustering of applications with noise’ (DBSCAN)
algorithm78 as described earlier79 and removed from the data set.
Channels of dual colour images were aligned by performing a spatial
transformation on the basis of a calibration measurement with multicolour
fluorescent beads (TetraSpeck microspheres 0.1 mm, Invitrogen) that are visible in
both spectral channels. For single molecule co-localization analysis, individual
molecules detected in both spectral channels were regarded as co-localized, if the
co-particle was found contemporaneously within a distance threshold of 2 pixels
(214 nm). In a consecutive step, co-localized particles were subjected to tracking by
the multiple-target tracing algorithm to generate co-trajectories. For the receptor
distance analysis, only trajectories with a minimum length of 30 steps (B960 ms)
were considered.
The diffusion characteristics were analysed by fitting of step-length histograms
(increment 32 ms or 1 frame, respectively) that were obtained from a collection of
single molecule trajectories of the labelled ligands with a minimum length of 150
frames (4.8 s). The utilized model is based on unhindered Brownian motion using a
two-component two-dimensional Gaussian probability distribution function.
PICCS44 was implemented into a MATLAB script to calculate the mean
correlated fraction of localized particles in channel 1 (TMRIL-13Ra1) with respect
to channel 2 (DY647IL-4Ra or DY647-labelled ligand) in a 20–25 mm2 region of
interest. Only the first 20 frames of each image stack were evaluated, as the
reduction of cross-correlation due to photobleaching was negligible during this
short time interval. The mean correlation function Ccum (r) was calculated from
the particle coordinates with the interval Dr¼ 0.03 mm and rmax¼ 0.7 mm
(r2max ¼ 0:49 mm2). First, the linear part of Ccum in the range of 0.1orr0.7 mm
was fitted using equation (1)
Clin:cum rð Þ ¼ r  pr2 þ a ð1Þ
to obtain the cross-correlated fraction a and the particle density r. Keeping these
parameters fixed, Ccum was fitted over the full range (0orr0.7 mm) with
equation (2)




þ r  pr2 ð2Þ
to obtain the correlation length s. The DOL was determined by PICCS analysis of
dual-colour images of HeLa cells expressing the type I interferon receptor subunit
IFNAR2 fused to both HaloTag and SNAPf-tag (HaloTag-SNAPf-IFNAR2c
(ref. 23)) that was labelled with HTL-TMR and BG-647. For HTL-TMR a mean
DOL of 32% and for BG-647 of 42% was determined. HaloTag-SNAPf-IFNAR2c
was also used as positive control to determine maximum single molecule co-
localization and the co-localization precision.
The molecular binding affinity KTD of IL-13Ra1 for ligand-bound IL-4Ra and of
IL-4Ra for IL-13-bound IL-13Ra1 in the plasma membrane was calculated
according to the law of mass action:
KTD ¼
IL 4Ra½   a  IL 13Ra1½ ð Þ  IL 13Ra1½   a  IL 13Ra1½ ð Þ
a  IL 13Ra1½  ð3Þ
The respective cell surface concentrations of IL-4Ra and IL-13Ra1 were taken from
the PICCS analyses (r, see above) and corrected for the determined DOLs. The
correlated fraction a was corrected for the basal a of unstimulated cells (caused by
random co-localizations and fitting fidelity) and normalized to the maximum
dimerization level (62%) that was obtained by setting the correlated fractions of the
DY647IL-4/TMRIL-13Ra1 (B18%) and DY647IL-4/TMRIL-4Ra (B28%) interactions
in relation. The error of the calculated KTD values depends on deviations of the
DOL, receptor concentrations and uncertainty in PICCS evaluation and was
estimated at ±50%.
Flow and phospho-flow cytometry. For quantification of receptor levels in the
plasma membrane, HeLa cells were stained at 4 C with Fluorescein-5-iso-
thiocyanate or Phycoerythrin labelled antibodies against IL-13Ra1 (1:100 dilution,
R&D cat: FAB1462F), IL-4Ra (1:100, BD Biosciences cat: 552178) and gc (1:100,
Biolegend cat: 338605) for 1 h. Cells were then washed, the levels of surface
receptors were measured and the mean fluorescence intensity was compared to an
isotype control.
STAT6 phosphorylation after treatment of HeLa cells with different ligands was
quantified by phospho-flow cytometry. After ligand incubation cells were fixed and
permeabilized with ice-cold methanol (100% v/v). Phosphorylated STAT6
(pSTAT6) was stained with a pTyr641-specific monoclonal antibody coupled to
Alexa Fluor 488 (1:50, BD Biosciences cat: 612600). The fluorescence was
quantified using an Accuri C6 flow cytometer (BD Biosciences) and background
corrected by subtracting the mean fluorescence intensity of an unstimulated
sample. Dose–response data were acquired 15 min after induction and the
normalized values were plotted against the cytokine concentration to yield dose–
response curves. These were fitted to a sigmoidal curve by nonlinear least squares
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regression for EC50 value calculation. The STAT6 phosphorylation kinetics was
quantified at a ligand concentration of 1 mM.
Model simulations. A simple spatial diffusion-reaction model (DAIDS) was
implemented in MATLAB (Version R2015a) that includes a submicroscopic,
semipermeable meshwork to mimic the MSK. The simulation with time-resolution
Dtsim consists of two massless molecular species (1: binary complex of ligand and
high affinity ligand-binding receptor subunit, 2: accessory receptor subunit) with
the corresponding particle surface concentrations N1 and N2. The particles are
diffusing with diffusion constant D according to a simple isotropic random walk
model80 in a two-dimensional space (plasma membrane), having the dimensions
8.99 8.99 mm (80.78 mm2) or 84 84 pixels (pixel-size 0.107 mm, taken from
experimental setup), respectively. The membrane is divided into right triangular
compartments with leg side lengths of 74.9 nm (0.7 pixel) that are arranged in an
alternating order (cf. Supplementary Fig. 20). Upon collision with the
compartment boundaries, particles are allowed to pass with a probability phop.
If each of a molecule of species 1 and 2 are getting closer together than a defined
association threshold da, a ternary complex is formed with probability pa. The
dissociation of ternary complexes occurs with probability pd. Further details of the
simulations are provided in the Supplementary Methods.
Code availability. Full, ready-to-use DAIDS code is available via figshare at
https://doi.org/10.6084/m9.figshare.4868180.v1. The ‘SLIMfast’ software package
for single molecule data evaluation is available on request from Christian P. Richter
(christian.richter@biologie.uni-osnabrueck.de).
Data availability. The data that support the findings of this study are available
from the authors on reasonable request (see author contributions for specific data
sets).
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